Alloanti‐ H y in antenatal patients: A multi‐case review
Transfusion Medicine · 2025
DOI: 10.1111/tme.13124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transfusion Medicine, 2025. Verfasst von S Lewis und 14 weiteren Autor:innen. Beteiligte Einrichtung: RCI, NHSBT, Birmingham, UK. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Isoantibodies. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Introduction
Introduction The Hy antigen is one of ten red cell antigens belonging to the Dombrock blood group system, with an antigen frequency of almost 100% in the majority of populations. Alloantibodies to high prevalence antigens cause difficulties with antibody identification and exclusion in serological investigations. Case Presentation This review describes the management of four antenatal cases where the presence of alloanti‐Hy had been identified. Hy‐red blood cell units may be required for the transfusion of patients with alloanti‐Hy, but currently, there are no published reports of alloanti‐Hy causing haemolytic disease of the fetus and newborn (HDFN). A previous case report involving the care and management of antenatal patients with alloanti‐Hy antibodies indicates a lack of evidence that alloanti‐Hy causes clinical HDFN.
Results
All cases discussed in this review demonstrate a reduction in the strength of alloanti‐Hy levels as pregnancy progressed. Signs or symptoms of HDFN were not observed with any of the pregnancies.
Conclusion
Factors such as antibody levels, antigenic expression, and varying clinical responses enhance our understanding of why alloanti‐Hy has not been known to cause clinical HDFN. The cases presented here aim to improve understanding of alloanti‐Hy in pregnancy and how to manage such cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RCI, NHSBT, Birmingham, UK.
- NIBTS, Belfast, UK.
- RCI, NHSBT, Liverpool, UK.
- Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, UK.
- IBGRL, NHSBT, Filton, UK.
- CSR Scientific Training, Birmingham, UK.
ORCID-Profile: T Bullock
Zitieren
APA
Lewis, S., Kirkpatrick, N., Nawrocki, A., Reyland, L., Jones, B., Laundy, R., McNeil, A., Crew, V. K., Stutt, T., Clinton, D., Anbazhagan, A., Harris, C., Skidmore, I., Bullock, T., & Hazell, M. (2025). Alloanti‐ H y in antenatal patients: A multi‐case review. Transfusion Medicine. https://doi.org/10.1111/tme.13124
Vancouver
Lewis S, Kirkpatrick N, Nawrocki A, Reyland L, Jones B, Laundy R, et al. Alloanti‐ H y in antenatal patients: A multi‐case review. Transfusion Medicine. 2025. doi:10.1111/tme.13124
BibTeX
@article{Lewis2025,
author = {Lewis, S and Kirkpatrick, N and Nawrocki, A and Reyland, L and Jones, B and Laundy, R and McNeil, A and Crew, V Karamatic and Stutt, T and Clinton, D and Anbazhagan, A and Harris, C and Skidmore, I and Bullock, T and Hazell, M},
title = {Alloanti‐ H y in antenatal patients: A multi‐case review},
journal = {Transfusion Medicine},
year = {2025},
doi = {10.1111/tme.13124}
}
EUVIMED